Filter News Category
Country
State / Province Select Country First
City / Town Select State First
| | Human Renin for clinical researchers available from Lee Biosolutions, Inc
| Lee Biosolutions, Inc announces increased inventory levels for high purity native human renin and high purity recombinant human renin for Clinical researchers world wide due to increase demand. |
FOR IMMEDIATE RELEASE
PRLog (Press Release) –
Nov 14, 2007 – ST. LOUIS , MO. Lee Biosolutions, Inc (http://www.leebio.com) announces increased inventory levels for high purity native human renin and high purity recombinant human renin for Clinical researchers world wide.
Renin is a key enzyme produced and released by the kidneys which initiates a cascade of reactions leading to the formation of Angiotensin II, which helps control sodium-potassium balance, fluid volume and blood pressure in the body. Renin plays a critical role in the diagnosis and treatment of a variety of conditions including hypertension, cirrhosis, renal tumors, Addisons disease, and Conns syndrome.
Human Renin (http://www.leebio.com/products/details.html?uid=249') acts as a proteolytic enzyme of the kidney by releasing angiotensin which has a vasoconstrictive action which results in a higher blood pressure. Early detection of Human renin level increases related to a blood pressure increase have shown in research to provide vital prognostic and diagnostic guidelines for evaluating possible surgical treatment especially in renovascular involvement
According to President ,Burton Lee recombinant Human renin ( http://www.leebio.com/products/details.html?uid=312 ) has been most popular among X-Ray crystallographers studying the Renin-Angiotensin System. Crystallographic Recombinant human renin is produced from crystallographic grade recombinant human pro-renin which is expressed in HEK cells, converted to renin, and the active enzyme was purified using peptide affinity chromatography.
Novartis Pharmaceuticals announced the first daily-dose Renin inhibitor to treat hypertension and improve organ protection in March 2005. Since then, Renin-based research has taken off and become the focus of numerous clinical studies.
Lee Biosolutions is a leader in the biomaterials industry, providing quality biomaterial products to clinical labs and researchers around the world, developing tomorrows cures. Leebio has provided human proteins used in a number of high profile biomarker studies. For more information or to place an order, contact
Lee Biosolutions, Inc
2924 Mary Ave
St. Louis, MO 63144
Tel:t 314-968-1091,
www.LeeBio.com.
# # #
Lee Biosolutions, Inc specializes in the development and purification of high quality BioMarkers for the Immunodiagnostic, clinical diagnostic and pharmaceutical industry worldwide. We supply reliable high quality human and animal enzymes and proteins, cardiac markers, tumor markers, acute phase proteins, coagulation proteins and immunoassay biomarkers
Email to a Friend
Email to Author
Visit Press Room
Previous News Next News
| Issued By | | : | Lee Biosolutions, Inc |
| Website | | : | http://www.leebio.com |
| Email | | : | Click to contact author |
| Phone | | : | 314-968-1091 |
| Address | | : | 2924 Mary Ave |
| City/Town | | : | St. Louis |
| State/Province | | : | Missouri |
| Zip | | : | 63144 |
| Country | | : | United States |
| Categories | | : | Health, Medical, Business |
| Tags | | : | Angiotensinogen, Renin, Research, Renin-angiotensin System, Kidney, Disease, Cancer, Health, Blood Pressure, Hypertension |
Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases.
PRLog.Org can't be held liable for the contents of the press releases.
Report Abuse
| |
Previous News
Next News
Are you a Journalist?
For Businesses ...
Tutorial on Free Marketing
| |